The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1386
ISSUE 1386
March 19, 2012
Issue 1386
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Statin Label Changes
March 19, 2012 (Issue: 1386)
Citing some recent reports, the FDA has announced
changes in the safety labeling of all HMG-CoA reductase
inhibitors (statins).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.